Payload Information
General Information of This Payload
| Payload ID | PAY0JJJPM |
|||||
|---|---|---|---|---|---|---|
| Name | Topoisomerase I inhibitor |
|||||
| Synonyms |
Topoisomerase I inhibitor
Click to Show/Hide
|
|||||
| Target(s) | DNA topoisomerase 1 (TOP1) | |||||
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
SKB-315 [Phase 1]
Identified from the Human Clinical Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Related Clinical Trial | |||||
| NCT Number | NCT05367635 | Phase Status | Phase 1 | ||
| Clinical Description |
A phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SKB315 for injection in patients with advanced solid tumors expressing claudin 18.2.
|
||||
References